Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286


Why Vitamin D Status Might be Important for Brain Health and Mental Well-Being?

Author(s): Flavia di Michele

Volume 26 , Issue 21 , 2020

Page: [2439 - 2441] Pages: 3

DOI: 10.2174/138161282621200520085710

Pilz S, Zittermann A, Trummer C, et al. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect 2019; 8(2): R27-43.
Cui X, Gooch H, Petty A, McGrath JJ, Eyles D. Vitamin D and the brain: Genomic and non-genomic actions. Mol Cell Endocrinol 2017; 453: 131-43.
AlJohri R, AlOkail M, Haq SH. Neuroprotective role of vitamin D in primary neuronal cortical culture. eNeurologicalSci 2018; 14: 43-8.
Lima LAR, Lopes MJP, Costa RO, et al. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats. J Neuroinflammation 2018; 15: 249.
Mayne PE, Burne THJ. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric Illness. Trends Neurosci 2019; 42(4): 293-306.
Logan VF, Gray AR, Peddie MC, et al. Long-term vitamin D3 supplementation is more effective than D2 in maintaining serum 25-hydroxy vitamin D status over the winter months. Br J Nutr 2013; 109: 1082-8.
Oxenkrug G. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets 2013; 14: 514-21.
Ali A, Cui X, Alexander S, Eyles D. Developmental vitamin D deficiency and autism: Putative pathogenic mechanisms. J Steroid Biochem Mol Biol 2018; 175: 108-18.
Yamamoto E, Jørgensen TN. Immunological effects of vitamin D and their relations to autoimmunity. J Autoimmun 2019. In press.
[ j.jaut.2019.03.002]
Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130: 226-38.
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014; 53: 23-34.
Kiraly DD, Horn SR, Van Dam NT, et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl Psychiatry 2017; 7(3) e1065
Haroon E, Woolwine BJ, Chen X, et al. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacol 2014; 39: 1777-85.
Li G, Mbuagbaw L, Samaan Z, et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 2014; 99: 757-67.
Khoraminya N, Tehrani-Doost M, Jazayeri S, et al. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 2013; 47: 271-5.
di Michele F, Siracusano A, Talamo A, Niolu C. N-Acetyl cysteine and vitamin d supplementation in treatment resistant obsessive - compulsive disorder patients: A general review. Curr Pharm Des 2018; 24: 1832-8.
Greene RK, Walsh E, Mosner MG, Dichter GS. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder. Biol Psychol 2019; 142: 1-12.
Vinkhuyzen AAE, Eyles DW, Burne THJ, et al. Gestational vitamin D deficiency and autism-related traits: The Generation R Study. Mol Psychiatry 2018; 23: 240-6.

© 2022 Bentham Science Publishers | Privacy Policy